![](data:image/svg+xml;charset=utf-8,<svg height="32" width="135" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
₹ 495.30
Open
502High
502Low
494.05Prev Close
500.05P/E
25.65Median P/E
31.46P/B
3.89Median P/B
4.43Market Cap
45.85BPEG
2.79Div.Yield
0.2Bid
495.35Ask
496.50Large Cap
45.85B Mkt. Cap.Volatility
-Beta
1.12Genie Says
Influencer Count
-| Days | BSE | NSE |
|---|
| 5 | 500.66 | 500.14 |
| 10 | 499.39 | 499.06 |
| 20 | 484.60 | 484.50 |
| 50 | 491.28 | 491.28 |
| 100 | 499.20 | 499.15 |
| 300 | 516.67 | 516.70 |
BSE
524348NSE
AARTIDRUGSISIN
INE767A01016Aarti Drugs Limited is an India-based company that is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include ciprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole and ofloxacin, among others. Its specialty chemicals products include benzene sulphonyl chloride and methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include itraconazole, fluconazole, dabigatran, ticagrelor, sitagliptin and alpha lipoic acid. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SPA.
Prakash Patil
Chairman of the Board, Chief Executive Officer, Managing Director, Executive DirectorAdhish Patil
Chief Financial Officer, Chief Operating OfficerRushikesh Deole
Compliance Officer, Company SecretaryHarshit Savla
Joint Managing Director, Executive DirectorRashesh Gogri
Managing Director, Executive DirectorUday Patil
Executive DirectorHarit Pragji Shah
Executive Director